JUAN GUZMAN: Open Payments
NPI 1972521045 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 43 payments from 9 companies in 2025. Trend: 2023 $341 · 2024 $495 · 2025 $576
Food & beverage: $549Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $309 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: VRAYLAR, COBENFY, ABILIFY ASIMTUFII, Auvelity, UZEDY, TRINTELLIX, FANAPT, CAPLYTA.
Industry payments across CA — which companies pay providers there.
